Intrathymic T-cell maturation critically depends on the selective expansion of thymocytes expressing a functionally rearranged T-cell receptor (TCR) beta chain. In addition, TCR-independent signals also contribute to normal T-cell development. It is unclear whether and how signals from the 2 types of pathways are integrated. Here, we show that T-cell factor-1 (TCF-1), a nuclear effector of the canonical wingless/int (wnt)/catenin signaling pathway, ensures the survival of proliferating, pre-TCR(+) thymocytes. The survival of pre-TCR(+) thymocytes requires the presence of the N-terminal catenin-binding domain in TCF-1. This domain can bind the transcriptional coactivator beta-catenin and may also bind gamma-catenin (plakoglobin). However, in the absence of gamma-catenin, T-cell development is normal, supporting a role for beta-catenin. Signaling competent beta-catenin is present prior to and thus arises independently from pre-TCR signaling and does not substantially increase on pre-TCR signaling. In contrast, pre-TCR signaling significantly induces TCF-1 expression. This coincides with the activation of a wnt/catenin/TCF reporter transgene in vivo. Collectively, these data suggest that efficient TCF-dependent transcription requires that pre-TCR signaling induces TCF-1 expression, whereas wnt signals may provide the coactivator such as beta-catenin. The 2 pathways thus have to cooperate to ensure thymocyte survival at the pre-TCR stage.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-01-0337DOI Listing

Publication Analysis

Top Keywords

pre-tcr signaling
16
ensure thymocyte
8
thymocyte survival
8
t-cell development
8
pre-tcr+ thymocytes
8
coactivator beta-catenin
8
signaling induces
8
induces tcf-1
8
tcf-1 expression
8
signaling
6

Similar Publications

IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.

Adv Exp Med Biol

July 2024

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch-Graffenstaden, France.

The IKAROS family of transcription factors comprises four zinc-finger proteins (IKAROS, HELIOS, AIOLOS, and EOS), which over the last decades have been established to be critical regulators of the development and function of lymphoid cells. These factors act as homo- or heterodimers and are involved both in gene activation and repression. Their function often involves cross-talk with other regulatory circuits, such as the JAK/STAT, NF-κB, and NOTCH pathways.

View Article and Find Full Text PDF
Article Synopsis
  • Relapsed T-acute lymphoblastic leukemia (T-ALL) has limited treatment options and this study explores resistance mechanisms to BH3 mimetics and the effectiveness of a new drug, NWP-0476, both alone and in combination.
  • The research used BH3 profiling and phosphokinase arrays to reveal that T-ALL cells rely on different proteins (BCL-xL and BCL-2) for survival, leading to the discovery of enhanced LCK and ACK1 activity in resistant cells as potential resistance factors.
  • The study concluded that targeting the LCK and ACK1 signaling pathways, along with combining BH3 mimetics and tyrosine kinase inhibitors, could offer a promising treatment strategy for relapsed T-
View Article and Find Full Text PDF
Article Synopsis
  • T cell development starts with genetic recombination of the TCRβ chain, which is evaluated at the β-selection checkpoint where most cells fail and die.
  • Researchers used the histone deacetylase 6 inhibitor ACY1215, revealing that it disrupts this checkpoint and highlights a crucial stage called "DN3b."
  • This stage involves up-regulation of certain proteins (TCR, CD28, CD5, Lef1) that influence TCR signaling strength, ultimately leading to successful progression beyond the β-selection checkpoint.
View Article and Find Full Text PDF

Establishing a multiplex imaging panel to study T cell development in the thymus in mouse.

STAR Protoc

September 2022

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, VIC, 3084, Australia; Immune Signalling Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000 Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3000, Australia. Electronic address:

Multiplexed immunohistochemistry enables analysis of cellular and signaling events in the context of an intact organ. Here, we describe protocols for applying multiplexed immunohistochemistry to the mouse thymus. In particular, we describe how to identify cells at the specific differentiation stage known as β-selection, and to monitor pre-TCR signaling and the cellular response at that stage.

View Article and Find Full Text PDF

A set point in the selection of the αβTCR T cell repertoire imposed by pre-TCR signaling strength.

Proc Natl Acad Sci U S A

May 2022

Immune System Development and Function Unit, Centro Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid (CSIC/UAM), 28049 Madrid, Spain.

Signaling via the T cell receptor (TCR) is critical during the development, maintenance, and activation of T cells. Quantitative aspects of TCR signaling have an important role during positive and negative selection, lineage choice, and ability to respond to small amounts of antigen. By using a mutant mouse line expressing a hypomorphic allele of the CD3ζ chain, we show here that the strength of pre-TCR–mediated signaling during T cell development determines the diversity of the TCRβ repertoire available for positive and negative selection, and hence of the final αβTCR repertoire.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!